Straumann Group

Switzerland · www.straumann.com · 8 vendors

Resilience scores

Technology vendors

Services catalogue

2 services in catalogue across 1 category; runs on 8 sub-vendors.

Insights

Last updated 2026-08-06 · revision 1

8 direct vendors, 172 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 6/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Straumann Group shows a good foundation for migration readiness through its adoption of several cloud-based and SaaS solutions, including Microsoft Azure, Salesforce CRM, Microsoft 365, and ServiceNow. The use of MuleSoft as an integration platform suggests an architectural approach that facilitates data and application movement, reducing monolithic dependencies. This existing cloud footprint indicates experience and capability in managing modern, distributed IT environments. However, several factors crucial for migration readiness are not available. There is no information on data residency requirements, the regulatory environment, or financial stability, which could impact the scope and funding of a migration project. A significant challenge in assessing migration readiness stems from the provided "Vendor Relationships" data, which states "Total Vendors: 0". This is inconsistent with the listed internal tech stack, which clearly relies on numerous major vendors (e.g., SAP, Adobe, Veeva). Without accurate vendor relationship details, it is impossible to properly assess vendor lock-in risks, contract complexities, and the effort required to migrate or replace vendor-dependent systems. While the company has modern cloud components, the migration of large enterprise systems like SAP ERP and Adobe Experience Manager could present significant challenges depending on their current customization and deployment models.

Financials

Three-year financials

Financial Resilience Score: 8/10

Straumann Group demonstrates strong financial resilience underpinned by global market leadership in dental implantology (>35% market share), a solid balance sheet with a 57.6% equity ratio, and a net cash position of CHF 135.6M at year-end 2025. The company generates consistent operating cash flow (CHF 512M in 2025) and maintains investment-grade financing, including a recently issued CHF 250M 3-year straight bond at a favorable 0.55% coupon. Its diversified portfolio spanning premium and value brands, broad geographic reach across four regions, and 18 local-for-local manufacturing sites provide resilience against tariffs, VBP procurement dynamics in China, and currency volatility. However, 2025 saw notable headwinds: net profit declined 22.1% to CHF 358.0M, ROE dropped from 23.1% to 16.9%, and gross margin compressed to 68.6% (from 76.2% in 2021), reflecting FX headwinds of over CHF 100M, US tariffs on Swiss and Brazilian imports, and mix shift toward challenger brands. Working capital intensity has risen from 6.1% (2021) to 16.4% (2025). Despite these pressures, organic growth of 8.9% remains healthy, core EBIT margin held at 25.2%, and the company has proposed its 10th consecutive annual dividend increase to CHF 1.00 per share, signaling management's confidence in ongoing cash generation and structural growth tailwinds from aging populations and rising dental care affordability.

Key strengths: Global market leadership with >35% share in CHF 6.1B implant market, Strong equity ratio of 57.6% and net cash position of CHF 135.6M, CHF 250M bond issuance at 0.55% coupon demonstrates strong credit access, Diversified portfolio across premium/value brands and four geographic regions, 18 local-for-local manufacturing sites mitigate tariff and geopolitical risk, Consistent operating cash flow of CHF 512M in 2025, 10 consecutive years of dividend increases, R&D investment at 5.2% of revenue driving innovation pipeline, Structural growth tailwinds from aging populations and rising affordability

Risk factors: Significant currency exposure - FX cost >CHF 100M in revenue and 130bps margin in 2025, China VBP 2.0 procurement pressure ahead of 2026 tender, US tariffs on Swiss and Brazilian imports impacting margins, Gross margin compression from 76.2% (2021) to 68.6% (2025), ROE decline from 23.1% to 16.9% in 2025, Rising working capital intensity (6.1% to 16.4% of revenue since 2021), CHF 578M goodwill plus CHF 82M indefinite-life brands (18% of assets) exposed to impairment, CHF 27.6M in legal provisions from competitor litigation, Orthodontics/ClearCorrect segment undergoing repositioning after DrSmile divestiture

Revenue by geography

Revenue by product/service

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report